Zoetis Inc. filings document the animal health company's operating results, capital returns, financing activity and governance disclosures. Recent 8-K reports furnish quarterly and annual financial results, guidance, dividend declarations, investor presentations and other Regulation FD disclosures.
The company's proxy materials address board and compensation matters, including executive pay and equity-award disclosures. Other filings record its New York Stock Exchange-listed common stock and debt financing, including a private offering of convertible senior notes, related indenture terms and capped call transactions.
Zoetis Inc. Chief Financial Officer Joseph Wetteny reported equity award activity and tax-related share withholding. On February 6, 2026, 1,388 restricted stock units vested and were settled into common shares, with 515 shares withheld at $127.42 per share for taxes. On February 8, 2026, another 1,409 units vested into common shares, with 483 shares withheld at $127.42 per share for taxes. After these transactions, Wetteny directly owned 20,766 shares of Zoetis common stock and held 6,152.6517 RSUs that remain outstanding.
Zoetis Inc. Executive Vice President Ferran Astorga Jeannette reported routine equity compensation activity involving restricted stock units (RSUs) and common stock. On February 6 and 8, 2026, RSUs vested and were settled into 206 and 218 shares of Zoetis common stock, respectively, with no cash exercise price.
To cover withholding obligations, the company withheld 92 and 97 shares of common stock at a price of $127.42 per share. After these transactions, the executive directly held 1,443 shares of Zoetis common stock and 1,294.6543 RSUs, which each represent a contingent right to receive one share of common stock as they vest over future anniversaries of the original grant dates.
Zoetis Inc. Executive Vice President Jamie Brannan reported routine equity compensation activity. On February 6 and 8, 2026, restricted stock units (RSUs) vested and were settled in Zoetis common stock, resulting in acquisitions of 529 and 380 shares, respectively.
To cover tax withholding on these vestings, 249 shares on February 6 and 179 shares on February 8 were withheld at a price of $127.42 per share. After these transactions, Brannan directly owned 2,652 shares of Zoetis common stock and held 445 common stock equivalents indirectly through the UK Share Ownership Plan.
The filing also shows 3,614.0741 RSUs outstanding under the Zoetis Amended and Restated 2013 Equity and Incentive Plan and related dividend equivalents, which represent contingent rights to receive the same number of Zoetis common shares upon future vesting.
Zoetis Inc. Executive Vice President Rimma Driscoll reported routine equity compensation activity involving restricted stock units (RSUs) and common stock. On February 6, 2026, 222 shares of common stock were acquired upon RSU vesting, and 89 shares were withheld at a price of $127.42 per share to cover taxes, leaving 5,325 shares of common stock directly owned. On February 8, 2026, a further 192 shares were acquired upon RSU vesting, with 77 shares withheld at $127.42 per share for taxes, resulting in 5,440 directly owned shares. The derivative table shows related RSU positions, including ongoing RSU awards that vest in thirds on the first, second, and third anniversaries of the original grant dates.
Zoetis Inc. Executive Vice President Keith Sarbaugh reported routine equity compensation activity. On February 6, 2026, 119 shares of common stock were acquired upon vesting and settlement of restricted stock units, and 48 shares were withheld at $127.42 per share to cover taxes.
After these transactions, Sarbaugh directly owns 2,110 shares of Zoetis common stock. He also holds time-based restricted stock units that each represent a contingent right to receive one share, including 120 RSUs from a February 6, 2024 grant, 1,528.0167 RSUs from a March 31, 2023 grant, and 1,159.7099 RSUs from a February 19, 2025 grant, all vesting in three equal annual installments subject to continued service.
Zoetis Inc. Chief Executive Officer and director Kristin C. Peck reported multiple equity transactions involving company stock and restricted stock units (RSUs). On February 6, 2026, RSU vesting led to the acquisition of 5,555 shares of common stock, followed by the disposition of 1,914 shares at $127.42 per share. On February 8, 2026, additional RSUs vested, generating 6,224 shares of common stock, with 2,722 shares disposed of at $127.42 per share.
After these transactions, Peck directly held 101,337 shares of Zoetis common stock and 833.6435 common stock equivalents in the Zoetis Savings Plan (401(k)) as of December 31, 2025, along with 22,062.8977 RSUs outstanding under the company’s equity incentive plan.
Zoetis Inc. declared a quarterly dividend of $0.53 per share for the second quarter of 2026. The dividend will be paid on June 2, 2026 to shareholders of record as of the close of business on April 20, 2026. The company also noted that the related information is being furnished under Regulation FD and not treated as filed for liability purposes.
Zoetis Inc. chief executive Kristin C. Peck reported an acquisition of 367.2079 phantom stock units on January 9, 2026, under the Zoetis Supplemental Savings Plan. These units are a form of deferred, cash-settled compensation whose value is tied to Zoetis common stock plus a small portion of cash-equivalent investments. After this transaction, Peck holds a total of 58,410.776 phantom stock units directly. Each unit represents a fraction of a phantom share of Zoetis common stock and typically includes around 5% of its value in cash-equivalent investments, so the total value moves with the Zoetis share price and the value of those cash-equivalent holdings.
Zoetis Inc. Executive Vice President Keith Sarbaugh reported an acquisition of derivative-based compensation tied to the company’s stock. On 01/09/2026, he acquired 149.604 phantom stock units under the Zoetis Supplemental Savings Plan at a reference value of $42.42 per unit, bringing his holdings in this plan-related instrument to 1,247.7606 phantom stock units held directly.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus a small amount of cash-equivalent investments, which typically account for around 5% of the unit’s total value. The units are settled in cash following his separation from service, and their value is determined by the market value of Zoetis common stock together with the value of the cash-equivalent investments.
Zoetis Inc. Executive Vice President Kevin Esch reported an award of cash-settled phantom stock units linked to Zoetis common stock. On 01/09/2026, he acquired 100.6422 phantom stock units at a reference value of $42.42 per unit, bringing his total to 277.038 phantom stock units.
The units were acquired under the Zoetis Supplemental Savings Plan and will be settled in cash after his separation from service. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus a small portion of cash-equivalent investments, with the value determined by the market price of Zoetis stock and the value of those cash-equivalent holdings.